Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Notes underwriting agrmnt
|
|
RADIENT PHARMACEUTICALS Corp (RXPC)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 05/06/2014 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
| 06/11/2013 |
8-K
| Entry into a Material Definitive Agreement, Departure of Directors or Certain Officers; Election of Directors; Appointment of... |
| 07/17/2012 |
8-K
| Form 8-K - Current report |
| 06/26/2012 |
8-K
| Form 8-K - Current report |
| 05/21/2012 |
8-K
| Entry into a Material Definitive Agreement, Other Events, Financial Statements and Exhibits |
| 04/30/2012 |
8-K
| Other Events |
| 04/03/2012 |
8-K
| Form 8-K - Current report |
| 03/28/2012 |
8-K
| Triggering Events That Accelerate or Increase a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arran... |
| 03/26/2012 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
| 03/06/2012 |
8-K
| Regulation FD Disclosure, Other Events |
| 02/29/2012 |
8-K
| Regulation FD Disclosure |
| 02/23/2012 |
8-K
| Triggering Events That Accelerate or Increase a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arran... |
| 12/01/2011 |
8-K
| Form 8-K - Current report |
| 11/29/2011 |
8-K
| Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance S... |
| 11/15/2011 |
8-K
| Form 8-K - Current report |
| 11/07/2011 |
8-K
| Form 8-K - Current report |
| 08/29/2011 |
8-K
| Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance S... |
| 08/22/2011 |
8-K
| Form 8-K - Current report |
| 08/15/2011 |
8-K
| Quarterly results |
| 08/02/2011 |
8-K
| Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance S... |
| 07/01/2011 |
8-K
| Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance S... |
| 06/23/2011 |
8-K
| Form 8-K - Current report |
| 06/08/2011 |
8-K
| Results of Operations and Financial Condition, Regulation FD Disclosure, Financial Statements and Exhibits |
| 06/02/2011 |
8-K
| Triggering Events That Accelerate or Increase a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arran... |
| 05/26/2011 |
8-K
| Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Other Events, Financial ... |
| 05/25/2011 |
8-K
| Form 8-K - Current report |
| 05/24/2011 |
8-K
| Results of Operations and Financial Condition, Regulation FD Disclosure, Financial Statements and Exhibits|
Docs:
|
"RADIENT PHARMACEUTICALS PROVIDES UPDATE REGARDING 2010 FORM 10K & FY 2011 Q1 10Q May 24, 2011/Marketwire – Radient Pharmaceuticals Corporation , a US-based company specializing in the research, development, and international commercialization of in vitro diagnostic cancer tests, announced today, that it intends to file its Annual Report on Form 10-K for the year ended December 31, 2010 after market today and anticipates filing its Quarterly Report on Form 10-Q for the quarter ended March 31, 2011 on or before the close of business on Tuesday, June 7, 2011. In the Form 10-Q, the Company expects to report revenues of approximately $31,000 and a net loss in the range of $10.6 – $12 million compared with net loss of approximately $2.6 million for the three months ended March 31, 2010. The Comp..." |
|
| 05/11/2011 |
8-K
| Triggering Events That Accelerate or Increase a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arran... |
| 04/28/2011 |
8-K
| Form 8-K - Current report |
| 04/28/2011 |
8-K
| Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Other Events, Financial ...|
Docs:
|
"RADIENT PHARMACEUTICALS RECEIVES NON-COMPLIANCE NOTICE FROM NYSE AMEX REGARDING ITS 10-K FILING April 28, 2011/Marketwire –Radient Pharmaceuticals Corporation announced today that, as anticipated, RPC received a letter dated April 25, 2011 from NYSE Amex, LLC stating that because RPC, as previously disclosed, did not file its annual report on Form 10-K for the year ended December 31, 2010 on or before April 15, 2011, RPC is non-compliant with Sections 134 and 1101 of the NYSE Amex Company Guide . Upon the occurrence of such noncompliance, the Exchange is required to issue a deficiency letter to the subject issuer and the Exchange rules require the subject issuer to publicly announce receipt of same. As RPC publicly announced in its April 21, 2011 press release, the Exchange’s Listing Qual..." |
|
| 04/21/2011 |
8-K
| Form 8-K - Current report |
| 04/18/2011 |
8-K
| Results of Operations and Financial Condition, Regulation FD Disclosure, Other Events, Financial Statements and Exhibits|
Docs:
|
"RADIENT PHARMACEUTICALS PROVIDES UPDATE REGARDING 2010 FORM 10K; ANTICIPATED RESULTS & NYSE AMEX HEARING March 1, 2011/Marketwire –Radient Pharmaceuticals Corporation , a US-based company specializing in the research, development, and international commercialization of in vitro diagnostic cancer tests, announced today, as disclosed in the Company’s Form 8-K filed with the Securities and Exchange Commission on April 14, 2011, that due to requests for financial information from and related to the Company’s deconsolidated Chinese subsidiary Jade Pharmaceuticals, Inc. , the Company is not able to complete its audited financial statements for the fiscal year ended December 31, 2010 in a timely manner, and is therefore unable to file its Form 10-K with the SEC by April 15, 2011 as required. JPI ..." |
|
| 03/22/2011 |
8-K
| Form 8-K - Current report |
| 02/23/2011 |
8-K
| Form 8-K - Current report |
|
|
|